Red scrotum syndrome: Idiopathic neurovascular phenomenon or steroid addiction?

Sexual Health

Volumn 10, Issue 5, 2013, Pages 452-455

  Narang, Tarun ^a   Kumaran, Muthu Sendhil ^a   Dogra, Sunil ^a   Saikia, Uma Nahar ^a   Kumar, Bhushan ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Silver Oaks Hospital   (India)

Author keywords

pregabalin; rebound vasodilation; rosacea like dermatosis; tetracyclines; topical corticosteroids

Indexed keywords

AMITRIPTYLINE; CORTICOSTEROID; DOXYCYCLINE; PREGABALIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DRUG DEPENDENCE; HISTOPATHOLOGY; HUMAN; MALE; PATCH TEST; RED SCROTUM SYNDROME; ROSACEA; SCROTUM DISORDER; SKIN BIOPSY;

ADMINISTRATION, TOPICAL; ADULT; AMITRIPTYLINE; DOXYCYCLINE; ERYTHEMA; GAMMA-AMINOBUTYRIC ACID; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCROTUM;

EID: 84886921597     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH13052     Document Type: Article

References (18)

1. Fisher BK. The red scrotum syndrome. Cutis 1997; 60: 139-41.
2. Abbas O, Kibbi AG, Chedraoui A, Ghosn S. Red scrotum syndrome: successful treatment with oral doxycycline. JDermatolog Treat 2008; 19: 371-2. doi: 10.1080/09546630802033858
3. Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol 2003; 21: 201-14. doi:10.1016/S0738-081X(02)00365-6
4. Rapaport MJ, Rapaport V. Serum nitric oxide levels in "red" patients: separating corticosteroid-addicted patients from those with chronic eczema. Arch Dermatol 2004; 140: 1013-4. doi: 10.1586/17469872. 1.4.547
5. Byun JW, Hong WK, Han SH, Song HJ, Lee HS, Choi GS, et al. Red scrotum syndrome: successful treatment with oral doxycycline. Int J Dermatol 2012; 51: 362-3. doi:10.1111/j.1365-4632.2010.04548.x
6. Wollina U. Red scrotum syndrome. J Dermatol Case Rep. 2011; 21(5): 38-41. doi:10.3315/jdcr.2011.1072
7. Prevost N, English JC. Case reports: red scrotal syndrome: a localized phenotypical expression of erythromelalgia. J Drugs Dermatol 2007; 6: 935-6.
8. Rapaport MJ. Red scrotum syndrome. Cutis 1998; 61: 128B.
9. Rubin MB. Red scrotum syndrome. Cutis 1998; 61: 28D.
10. Markos AR. Dysaesthetic penoscrotodynia: nomenclature, classification, diagnosis and treatment. Int J STD AIDS 2011; 22: 483-7. doi: 10.1258/ijsa.2011.010451
11. Mancuso G, Berdondini RM. Simultaneous occurrence of dysaesthetic peno/scroto-dynia and stomatodynia. Int J STD AIDS 2005; 16: 830-1. doi:10.1258/095646205774988154
12. Rapaport M. Rebound vasodilation from long-term topical corticosteroid use. Arch Dermatol 2007; 143: 264-76. doi:10.1001/archderm.143.2.268-b
13. Rapaport MJ, Rapaport VH. Serum nitric oxide levels in 'red' patients: separating corticosteroid-addicted patients from those with chronic eczema. Arch Dermatol 2004; 140: 1013-4. doi:10.1001/archderm. 140.8.1013
14. Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006; 54: 258-65. doi: 10.1016/j.jaad.2005.10.004
15. Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 2010; 299: C5398. doi:10.1152/ajpcell. 00047.2010
16. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2011; 3CD007938.
17. Moraska AR, Atherton PJ, Szydlo DW, Barton DL, Stella PJ, Rowland KM. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation study-NCCTG trial N00CB. J Support Oncol 2010; 8: 128-32.
18. Hall E, Frey BN, Soares CN. Non-hormonal treatment strategies for vasomotor symptoms: a critical review. Drugs 2011; 71: 287-304. doi: 10.2165/11585360-000000000-00000